Trial intelligence / Profile preview

Bicarbonate infusion for intraoperative hemorrhagic shock

IRCT20130304012695N5Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of sodium bicarbonate in hemorrhagic shock and metabolic acidosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Blood pressure, Acidosis and 1 more. Started Jun 2019; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

hemorrhagic shockmetabolic acidosis

Beyond the preview

Go deeper on IRCT20130304012695N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130304012695N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call